Zusammenfassung
Das Retinoblastom ist der häufigste maligne intraokulare Tumor des Kindesalters. Die Erkrankung betrifft ein Auge oder beide Augen. Sie kann sporadisch oder familiär gehäuft vorkommen. Die Inaktivierung beider Allele des Tumorsuppressorgens RB1 (Chromosom 13) ist Ursache für ein Retinoblastom. Individuen mit konstitutioneller Heterozygotie für eine Rb1-Mutation haben zusätzlich ein erhöhtes Risiko für die Entstehung unabhängiger Zweittumoren. Durch eine Kombination verschiedenster Therapiemethoden liegt die Heilungsrate bei rein intraokularer Erkrankung bei nahezu 100%, während bei Patienten mit disseminierter metastasierter Erkrankung erst in den letzten Jahren eine kurative Behandlung möglich wurde.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abramson DH, Frank CM (1998) Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105:573–579
Anteby I et al (1998) Ocular and orbital complications following the treatment of retinoblastoma. Eur J Ophthalmol 8:106–111
Bellaton E et al (2003) Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol 87:327–329
Bornfeld N et al (1997) Preliminary results of primary chemotherapy in retinoblastoma. Klin Padiatr 209: 216–221
Brehm A et al (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:598–601
Chan HSL et al (1996) Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without radiation. Clin Cancer Res 2:1499–1508
Chantada G et al (2004) Results of a prospective study for the treatment of retinoblastoma. Cancer 100: 834–842
Donaldson SS et al (1993) Retinoblastoma. In: Pizzo PA, Poplack DG (eds) Princples and practice of pediatric oncology, 2nd ed, pp 683–96. Lippincott Williams & Wilkins, Philadelphia
Doz F et al (1995) Etoposide and carboplatin in extraocular retinoblastoma: a study by the Societe Francaise d’Oncologie Pediatrique. J Clin Oncol 13:902–909
Draper GJ et al (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53:661–671
Draper GJ et al (1992) Patterns of risk of hereditary retinoblastoma and applications to genetic counseling. Br J Cancer 66:211–219
Dunkel IJ et al (2000) Successful treatment of metastatic retinoblastoma. Cancer 89:2117–2121
Ellsworth RM (1977) Retinoblastoma. Mod Probl Ophthalmol 18: 94–100
Eng C et al (1993) Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121–1128
Friend SH et al (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646
Hauffa BP et al (1995) Growth and development in children and adolescents after surgery, irradiation and chemotherapy for retinoblastoma. Monatsschr Kinderheilkd 143:1091–1098
Hermanek P et al (1987) TNM Klassifikation maligner Tumoren. Springer, Heidelberg Berlin New York
Imhof S et al (1997) Second primary tumours in hereditary-and non-hereditary retinoblastoma patients treated with megavoltage external beam irradiation. Doc Ophthalmol 93:337–344
Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823
Kremens B et al (2003) High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 31:281–284
Linn Murphree A (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18:41–53
Lohmann DR et al (1996) The spectrum of germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58: 940–949
Lohmann DR et al (1997) Molekulare Genetik und Diagnostik des Retinoblastoms. Ophthalmologe 94:263–267
Magnaghi-Jaulin L et al (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605
McCormick B et al (1988) Radiation therapy for retinoblastoma: comparison of results with lens-sparing versus lateral beam techniques. Int J Radiat Oncol Biol Phys 15:567–574
Migdal C (1983) Bilateral retinoblastoma: the prognosis for vision. Br J Ophthalmol 67:592–595
Moll AC et al (1997) Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet 18:27–34
Namouni F et al (1997) High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 33: 2368–2375
Paulino A (1999) Trilateral retinoblastoma. Cancer 86:135–141
Schipper J (1983) An accurate and simple method for megavoltage radiation therapy of retinoblastoma. Radiother Oncol 1:31–41
Schüler AO et al (2003) Thermochemotherapy in hereditary retinoblastoma. Br J Ophthalmol 87:90–95
Shields CL et al (1994) Optic nerve involvement of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 73:692–698
Shields CL et al (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104:2101–2111
Shields CL et al (2001) Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 108:2116–2121
Shields CL et al (2002) Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 120:1653–1658
Schvartzman E et al (1996) Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 14:1532–1536
Vogel F (1979) Genetics of retinoblastoma. Hum Genet 52:1–54
Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323–30
Weintraub SJ et al (1995) Mechanisms of active transcriptional repression by the retinoblastoma protein. Nature 375:812–815
Wilson TW et al (1996) Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits. Arch Ophthalmol 114:1390–1395
Wong FL et al (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278: 1262–12
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Wieland, R., Havers, W. (2006). Retinoblastome. In: Gadner, H., Gaedicke, G., Niemeyer, C., Ritter, J. (eds) Pädiatrische Hämatologie und Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29036-2_67
Download citation
DOI: https://doi.org/10.1007/3-540-29036-2_67
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-03702-6
Online ISBN: 978-3-540-29036-0
eBook Packages: Medicine (German Language)